Skip to main content
. Author manuscript; available in PMC: 2021 Jan 28.
Published in final edited form as: Liver Res. 2020 Nov 8;4(4):212–217. doi: 10.1016/j.livres.2020.11.002

Fig. 1. YAP1 immunoreactivity in benign cirrhotic liver, HCCs and hepatoblastoma.

Fig. 1.

(A, B) The HCC case showing positive YAP1 in the ductules surrounding the cirrhotic nodules (A, H&E staining), but negative in the HCC cells and normal hepatocytes. (C) Another HCC case showing focally and moderately positive YAP1 in the HCC cells. (D) A hepatoblastoma case showing moderately to strongly positive YAP1 in the tumor cells. (A–D, 400×). D denotes ductule in Fig. 1A. Abbreviations: YAP1, Yes-associated protein-1; HCC, hepatocellular carcinoma; H&E, hematoxylin-eosin.